Our Founders
Our Founder & Co-Founder
OncoMenopause™ was founded by Lisa Larkin, MD, FACMP, MSCP, IF, and co-founded by Maryam Lustberg, MD, MPH, as a permanent national education initiative of HERmedicine, a 501(c)(3) nonprofit organization dedicated to advancing evidence-based women’s health through education, collaboration, and community.
The initiative is advanced through the OncoMenopause Consortium®, the multidisciplinary professional community created to bring together expertise across oncology, menopause medicine, primary care, gynecology, sexual health, survivorship care, and related disciplines.
Dr. Larkin serves as Founder and Executive Director of HERmedicine and oversees OncoMenopause as part of the organization’s broader educational mission. Dr. Lustberg serves on the HERmedicine Board of Directors and as Co-Founder and Chair of the OncoMenopause Consortium, helping lead its clinical and educational direction.
Together, they established OncoMenopause to address the complex and historically neglected intersection of cancer survivorship, menopause, and midlife women’s health. Through rigorous evidence-based education, multidisciplinary collaboration, respectful clinical discourse, and community-building, the initiative works to improve care for women affected by cancer.
Lisa Larkin, MD, FACP, MSCP, IF
Lisa Larkin, MD, FACP, MSCP, IF, is a leader in internal medicine and women’s health with more than three decades of clinical experience and the unique perspective of being a breast cancer survivor. She is the founder of HERmedicine, a national 501(c)(3) nonprofit advancing evidence-based women’s health, and the founder and president of Ms.Medicine.
A Fellow of the American College of Physicians, a Certified Menopause Practitioner, and a Fellow of ISSWSH, Dr. Larkin maintains an active concierge internal medicine and women’s health practice focused on evidence-based care and long-term patient relationships.
She provides executive women’s health consultations and telemedicine services across multiple states, with expertise in menopause, sexual health, and preventive medicine. Dr. Larkin is recognized nationally for her leadership, innovation, and commitment to elevating standards of care in women’s health.
Maryam Lustberg, MD, MPH
Maryam Lustberg, MD, MPH, is a breast medical oncologist and serves as Chair of the OncoMenopause Education Committee and a member of the HERmedicine Board of Directors. She is currently Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven, Connecticut.
Dr. Lustberg is the co-chair of Symptom Intervention for the National Cancer Institute Alliance Clinical Trials and the immediate Past President of MASCC, an international organization dedicated to improving cancer supportive care worldwide. Her research focuses on biomarkers of therapeutic response and toxicity, cancer treatment symptom management, and the optimization of survivorship care.